Hu Y - Search Results

1

Effect of the normal liver mean dose on intrahepatic recurrence in patients with hepatocellular carcinoma after receiving liver stereotactic body radiation therapy.

Wu QQ, Chen YX, Du SS, Hu Y, Yang P, Sun J, Wang XY, Wu WX, Zhang SM, Zeng ZC. Wu QQ, et al. Among authors: hu y. Transl Oncol. 2022 Nov;25:101492. doi: 10.1016/j.tranon.2022.101492. Epub 2022 Aug 6. Transl Oncol. 2022. PMID: 35944415 Free PMC article.

2

Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma.

Zhuang Y, Yuan BY, Chen GW, Zhao XM, Hu Y, Zhu WC, Zeng ZC, Chen YX. Zhuang Y, et al. Among authors: hu y. Front Oncol. 2019 Sep 10;9:896. doi: 10.3389/fonc.2019.00896. eCollection 2019. Front Oncol. 2019. PMID: 31552194 Free PMC article.

3

Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients.

Zhang Y, Li Z, Chen Y, Yang P, Hu Y, Zeng Z, Du S. Zhang Y, et al. Among authors: hu y. Transl Oncol. 2022 Dec;26:101537. doi: 10.1016/j.tranon.2022.101537. Epub 2022 Sep 15. Transl Oncol. 2022. PMID: 36115075 Free PMC article.

4

Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.

Ye L, Shi S, Zeng Z, Huang Y, Hu Y, He J. Ye L, et al. Among authors: hu y. Jpn J Clin Oncol. 2018 Feb 1;48(2):160-166. doi: 10.1093/jjco/hyx179. Jpn J Clin Oncol. 2018. PMID: 29253245

5

A sequence polymorphism on 8q24 is associated with survival in hepatocellular carcinoma patients who received radiation therapy.

Zhao XM, Xiang ZL, Chen YX, Yang P, Hu Y, Zeng ZC. Zhao XM, et al. Among authors: hu y. Sci Rep. 2018 Feb 2;8(1):2264. doi: 10.1038/s41598-018-20700-x. Sci Rep. 2018. PMID: 29396413 Free PMC article.

6

Toll-like receptor 4 and its associated proteins as prognostic factors for HCC treated by post-radiotherapy surgery.

Wu ZF, Wang Y, Yang P, Hou JZ, Zhang JY, Hu Y, Zeng ZC. Wu ZF, et al. Among authors: hu y. Oncol Lett. 2018 Jun;15(6):9599-9608. doi: 10.3892/ol.2018.8583. Epub 2018 Apr 26. Oncol Lett. 2018. PMID: 29928336 Free PMC article.

7

Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy.

Shi S, Ye L, Zhao Q, Hu Y, Huang Y, Chen G, Zeng Z, He J. Shi S, et al. Among authors: hu y. Jpn J Clin Oncol. 2019 Apr 1;49(4):367-372. doi: 10.1093/jjco/hyy205. Jpn J Clin Oncol. 2019. PMID: 30715411

8

Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma.

Zhang H, Chen Y, Hu Y, Yang P, Wang B, Zhang J, Sun J, Zeng Z. Zhang H, et al. Among authors: hu y. Ann Palliat Med. 2019 Nov;8(5):717-727. doi: 10.21037/apm.2019.11.17. Ann Palliat Med. 2019. PMID: 31865732 Free article.

9

Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy.

Zhuang Y, Yuan BY, Hu Y, Chen GW, Zhang L, Zhao XM, Chen YX, Zeng ZC. Zhuang Y, et al. Among authors: hu y. Cancer Manag Res. 2019 Dec 31;11:10929-10937. doi: 10.2147/CMAR.S231901. eCollection 2019. Cancer Manag Res. 2019. PMID: 32099457 Free PMC article.

10

DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Du S, Chen G, Yuan B, Hu Y, Yang P, Chen Y, Zhao Q, Zhou J, Fan J, Zeng Z. Du S, et al. Among authors: hu y. Cell Mol Immunol. 2021 Jul;18(7):1718-1728. doi: 10.1038/s41423-020-0395-x. Epub 2020 Mar 19. Cell Mol Immunol. 2021. PMID: 32203191 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,989 results

Search Page

Filters